0 seconds from now
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
for the First Time at Havana International Trade FairMinister Myint's presence at the Havana Fair is expected to boost those intentions. In fact, has already registered two Cuban biopharmaceuticals for cancer treatment and has shown interest in other products developed by the Caribbean ...
flu vaccine in $425 million BioNTech allianceFRANKFURT (Reuters) - Pfizer has agreed to pay German firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.Pfizer - Home | Facebook
BeiGene raises $903 million in HK's first secondary listing under new rules: sourcesHONG KONG (Reuters/IFR) - Chinese Nasdaq-listed BeiGene Ltd has raised $903 million after pricing its secondary listing in Hong Kong - the first under new exchange rules - near the top of an indicative range, three people close to the deal said Chinese firm Ascletis opens higher in Hong Kong debut
Zai Lab plans Hong Kong float: sourcesHONG KONG (Reuters/IFR) - Zai Lab Ltd (ZLAB.O) is planning a Hong Kong float after its Nasdaq debut last year, in what would be the second U.S.-listed Chinese firm to return to the city following an implementation of new listing rules, sources US-listed Chinese Zai Lab plans Hong Kong float
drugLONDON/NEW YORK (Reuters) - U.S. drugmaker AbbVie ABBV.N faces a crunch moment in Europe in mid-October when less-expensive copies of its $18-billion-a-year biologic drug Humira – the world's best-selling prescription medicine – hit the market.
Metals completes scoping study for US$191 million China open pit at Bawdwin mine Metals Limited (ASX:MYL) has shared results of a CSA Global Pty Ltd scoping study for an open pit for the China lode at Bawdwin silver-lead-zinc project in , giving the starter pit a 13-year mine life. The company, previously known as
firm Ascletis raises $400 million in HK IPO: sourcesHONG KONG (Reuters/IFR) - Chinese Ascletis Pharma Inc (1672.HK) raised $400 million after pricing its IPO in the middle of an indicative range, three people said, in the first such Hong Kong listing under rules designed to attract early-stage
Army Chief Urges Soldiers to Obey LawYANGON (Reuters) - army chief Min Aung Hlaing has told military personnel in the country that they must obey the law, citing as an example the sentencing of seven soldiers for a massacre of Rohingya Muslim men that was the subject of a Reuters ...